Drugs / Infanrix/Hib™
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01345240 Background | Nov 2011 → Jan 2013 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01345240 ↗ |
| Modality | Vaccine | “Infanrix/Hib™ vaccine” NCT01345240 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT01345240 ↗ |